BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
DCOM
Dime Community Bancshares, Inc.
DCOM has the edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
DCOM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
DCOM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like DCOM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over DCOM in the historical PE scenario, which offers more potential upside but is not a forecast.
DCOM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.9x | $24.18 | -43% |
| Forward | 10x | $42.23 | — |
| Fair | 13x | $40.73 | -3.5% |
| Current | 14x | $42.23 | — |
| Expensive | 24x | $74.84 | +77% |
Historical ranges are pointers, not guarantees.
DCOM's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
DCOM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for DCOM, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
DCOM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | +33% |
| Q3 2026 | $3.08 | +180% |
| Q2 2026 | $2.77 | +246% |
| Q1 2026 | $2.66 | +351% |
| Q4 2025 | $2.36 | +329% |
| Q3 2025 | $1.10 | -27% |
| Q2 2025 | $0.80 | -48% |
| Q1 2025 | $0.59 | -67% |
| Q4 2024 | $0.55 | -76% |
DCOM earned $3.08 per share over the past year, up 180% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
DCOM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $135.3M | +17% |
| Q2 2026 | $126.5M | +15% |
| Q1 2026 | $123.6M | +19% |
| Q4 2025 | $123.8M | +116% |
| Q3 2025 | $115.6M | +32% |
| Q2 2025 | $109.7M | +26% |
| Q1 2025 | $103.8M | +27% |
| Q4 2024 | $57.2M | -31% |
DCOM's revenue has grown year over year for seven quarters in a row: $135M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +6.7 points |
| Q2 2026 | 38% | +1.2 points |
| Q1 2026 | 39% | +12 points |
| Q4 2025 | 39% | +69 points |
| Q3 2025 | 35% | +14 points |
| Q2 2025 | 37% | +6.8 points |
| Q1 2025 | 28% | -2 points |
| Q4 2024 | -30% | -60 points |
DCOM has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
DCOM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $107.9M | +111% |
| Q1 2026 | $48M | -27% |
| Q4 2025 | $46M | -48% |
| Q3 2025 | $51.2M | +$84.5M |
| Q1 2025 | $65.4M | +113% |
| Q4 2024 | $89M | +$129.1M |
| Q3 2024 | -$33.3M | -139% |
| Q2 2024 | $12.6M | -60% |
DCOM has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over DCOM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
DCOM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -81.2K shares |
| 1 year | +0.2% | +84.5K shares |
| 3 years | +13% | +4.9M shares |
| 5 years | +6.7% | +2.7M shares |
DCOM has 43M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $232,000 |
| Q1 2023 | $715,000 |
| Q4 2022 | $264,000 |
| Q3 2022 | $6.2M |
| Q2 2022 | $22.9M |
| Q1 2022 | $17.4M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
DCOM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -9.6x | Net Cash |
| Q2 2026 | -9.0x | Net Cash |
| Q1 2026 | -10.1x | Net Cash |
| Q4 2025 | -12.9x | Net Cash |
| Q3 2025 | -14.9x | Net Cash |
| Q2 2025 | -11.8x | Net Cash |
| Q1 2025 | -12.4x | Net Cash |
| Q4 2024 | -16.8x | Net Cash |
DCOM has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
DCOM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.7 | Neutral |
| Stochastic | 66.5 | Neutral |
DCOM's weekly RSI is 62 (neutral) and its Stochastic is 66 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over DCOM on valuation relative to its sector.
DCOM PE vs Financial Services Sector
| Metric | DCOM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 5.3% above |
| PE % | 52 | 63 | 11 pts below |
DCOM is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
DCOM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.8 | 3.6% above |
| 20 week MA | $40.6 | 4% above |
| 50 week MA | $36.9 | 15% above |
| 100 week MA | $32.7 | 29% above |
| 200 week MA | $27.9 | 51% above |
DCOM has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
DCOM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.7 | $24.5 | -27% |
| 2021 | $24.5 | $34.4 | +41% |
| 2022 | $34.4 | $32.0 | -7.1% |
| 2023 | $32.0 | $26.9 | -16% |
| 2024 | $26.9 | $30.7 | +14% |
| 2025 | $30.7 | $31.2 | +1.8% |
| 2026 YTD | $31.2 | $42.2 | +35% |
DCOM has the edge over BAC on returns for 2026, with the stronger performance.